Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element - Test2 - elhamkhani - TriplyDB

Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element

Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element

http://www.wikidata.org/entity/Q28646726

about

The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation A negative elongation factor for human RNA polymerase II inhibits the anti-arrest transcript-cleavage factor TFIIS.The Drosophila 7SK snRNP and the essential role of dHEXIM in development 7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription Molecular characterization of Drosophila NELF A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure Coupling pre-mRNA processing to transcription on the RNA factory assembly line Cyclin Box Structure of the P-TEFb Subunit Cyclin T1 Derived from a Fusion Complex with EIAV Tat Crystal structure of the human transcription elongation factor DSIF hSpt4 subunit in complex with the hSpt5 dimerization interface Cracking the control of RNA polymerase II elongation by 7SK snRNP and P-TEFb Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes Up-regulation of P-TEFb by the MEK1-extracellular signal-regulated kinase signaling pathway contributes to stimulated transcription elongation of immediate early genes in neuroendocrine cells The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2 CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation Repression of RNA polymerase II elongation in vivo is critically dependent on the C-terminus of Spt5.Regulation of RNA polymerase II termination by phosphorylation of Gdown1.Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.Phosphorylation of serine 177 of the small hepatitis delta antigen regulates viral antigenomic RNA replication by interacting with the processive RNA polymerase II.Human negative elongation factor activates transcription and regulates alternative transcription initiation.Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse.Mechanism and factors that control HIV-1 transcription and latency activation The Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assembly Ubiquitylation of Cdk9 by Skp2 facilitates optimal Tat transactivation.Interactions between DSIF (DRB sensitivity inducing factor), NELF (negative elongation factor), and the Drosophila RNA polymerase II transcription elongation complex Transcriptional and posttranscriptional regulation of HIV-1 gene expression BET bromodomain inhibition as a novel strategy for reactivation of HIV-1 Control of transcriptional elongation.RNA polymerase II transcription elongation and Pol II CTD Ser2 phosphorylation: A tail of two kinases.RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.Enhancer RNA facilitates NELF release from immediate early genes The RNA polymerase II CTD coordinates transcription and RNA processing.Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.CDK9 and H2B monoubiquitination: a well-choreographed dance.The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective.Properties of RNA polymerase II elongation complexes before and after the P-TEFb-mediated transition into productive elongation.Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications.

P2860

Q24323313-8796F91A-044C-4786-AF9F-7A98DFD5243F Q24536049-6E9A034C-3430-40FF-AD26-BA0812624E43 Q24597477-BD6F8B70-CAC8-46CE-B85D-8E607E18B8DB Q24634280-088D1F35-11BE-4B86-92C3-CCEDD44275FB Q24684924-D8C724BE-83C1-48D6-90E0-9F29700F1BA1 Q24798796-70C4D22E-4F33-40D0-8E9A-0D58FC45DF24 Q24804709-A6ABE37F-7A0B-43C8-B4C2-EE428A1635C3 Q26999858-12034F8F-F5BD-40AF-8020-5561665E603E Q27024720-89DE537D-4933-4B46-9ACF-5238C79D832E Q27645094-8D6EBFD9-CA78-4936-84B5-F15F5E5559EB Q27657998-FF90B0AF-AC36-4FFB-8AF9-08FF112DB5EF Q28276848-3A8FE720-E5E5-4B63-8321-A78A6CA7030C Q28478188-AA128F3D-36B1-4DBF-B791-5F63EC8DBD9F Q28487524-61C0A238-3C5C-4E54-AB67-4B1BBAE6E45C Q28572356-66F12C7D-555D-481F-8F41-12DB650AAD74 Q28595060-EF161A20-D7FC-4812-BC1F-5C4814C54100 Q30429511-6472F689-81D2-4010-B755-06D1C8B7AED6 Q33501748-FD1C0D64-1185-4E76-83AD-3372DE3D4865 Q33556203-2C772FA4-E5AF-4C48-918E-FBE0FBB2226C Q33602605-15E9F9AC-23E2-4A08-B7C7-EF92FE59B1EB Q33614472-3359C12F-0420-45B3-8837-D30D6313E764 Q33673701-37FAEA39-A699-4701-A55D-2DD9DBF4FB2F Q33815611-DA6E5545-096D-4FDF-AE8F-9ACA501EDF09 Q33826920-28D9EC79-922A-4077-8AB3-826603101F22 Q33893725-12BD50F3-9AC8-463F-B974-45CB1F6472EC Q33930482-0019AB18-546C-48E5-BB80-5AF063E286A4 Q33953149-044D9ECA-D747-4CAC-BB8D-4A2FBC2CA2C8 Q34030804-074E5561-5EE3-4FD8-B41A-6046C46B8DC8 Q34032827-A6E3C6DC-1AA2-452C-A51E-1F290EB0BEE9 Q34038245-695DA26B-DBF6-4000-8967-B934148E5A4E Q34046663-B0C5DFCC-3D2A-47FA-8AD7-F80A86BFCD03 Q34064221-30D9A19A-8B63-48D6-9BC0-6402B0E78673 Q34292008-AFD8D52B-29B0-4AB1-9353-212894D42337 Q34303212-080DCDF4-7DE8-4AF4-BF1B-8602AD6957E7 Q34353375-E6964205-5506-44D1-A37C-41992B9A824D Q34372370-0C7FD0C4-59CD-4F9A-886E-5BC6CA4A5104 Q34544409-D60D39B5-8A2A-4380-94D0-6FCD1A7B9EA8 Q34650866-D4997706-E61C-4964-871F-4D6010DA3779 Q34654219-F1EABABA-B9C5-40D3-81B9-AFE6E378A513 Q34656952-8B4FA6BE-C662-46A2-8F65-0D5E4BB9CCF6

P2860

Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element

http://www.wikidata.org/entity/Q28646726

description

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2004

@ast

im Januar 2004 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2004/01/01)

@sk

vědecký článek publikovaný v roce 2004

@cs

wetenschappelijk artikel (gepubliceerd op 2004/01/01)

@nl

наукова стаття, опублікована в січні 2004

@uk

مقالة علمية (نشرت عام 2004)

@ar

name

Dynamics of human immunodefici ...... ansactivation response element

@ast

Dynamics of human immunodefici ...... ansactivation response element

@en

Dynamics of human immunodefici ...... ansactivation response element

@nl

type

label

Dynamics of human immunodefici ...... ansactivation response element

@ast

Dynamics of human immunodefici ...... ansactivation response element

@en

Dynamics of human immunodefici ...... ansactivation response element

@nl

prefLabel

Dynamics of human immunodefici ...... ansactivation response element

@ast

Dynamics of human immunodefici ...... ansactivation response element

@en

Dynamics of human immunodefici ...... ansactivation response element

@nl

P1433

Q28646726-7797512B-B4EF-4751-966E-7CE7248A60C8

P1476

Q28646726-237A473A-EEAD-44BF-9EB6-BA8BC3EA7577

P2093

Q28646726-2F037B5B-B10F-4F9E-90F6-80FBE3E1F370

Q28646726-38898940-0621-4EA5-BBA8-476B2C0F11A4

Q28646726-42A9EF00-EFDA-4551-BD5C-540DB0763F58

Q28646726-A87FC638-A70B-4581-93F1-3D9CC63C9E3F

Q28646726-D3D0472C-E665-49A5-8520-7647E079830E

Q28646726-E351D64C-6AE4-4612-BFE1-F1AB574B6780

P2860

Q28646726-02BD5EF1-21F8-49BD-8C68-E7841F470E44

Q28646726-041FEF5A-17A4-49B3-81EC-61A678B5A908

Q28646726-07A4BCE0-2B18-49B2-A390-B4CD59A71FD7

Q28646726-0D34AD2B-BD98-48C1-9457-55EAC2428197

Q28646726-0D4AA258-1A39-4462-8D6E-F6CDF3B49D33

Q28646726-1C52D987-7F68-4072-8276-D0AC2ED48E99

Q28646726-2E647428-95A0-47FB-9252-13DC90AADE0B

Q28646726-30B973AC-3AC7-484F-A037-C086EC054485

Q28646726-36BF6960-4E6E-4081-84ED-65C6C65C87B8

Q28646726-3D1D3C53-7978-4400-8680-C6D58E67BAD2

P304

Q28646726-119D5FE3-F151-466B-9D28-A7CF68A475F9

P31

Q28646726-128FE29B-D01C-4412-9C11-02356CF77E4B

P3181

Q28646726-B4F7F17D-8D56-4620-BB07-6D604249914E

P356

Q28646726-2A3E6CBD-6A49-4449-A637-C6CC680DF80E

P407

Q28646726-F96EB4BB-D591-4DB5-86FE-73A9C7D95479

P433

Q28646726-68019D3C-CFE0-4DA6-8D26-6723CC03DBFA

P478

Q28646726-5D95313C-44D0-4FF4-9D33-CDB634C7EA4E

P577

Q28646726-D4B6D737-B422-4D2A-9B7D-5461D9231C10

P5875

Q28646726-F7309A32-6F18-435A-8B4B-849A1D7D136A

P698

Q28646726-BFE8BAD9-5B86-495A-95E9-134C754CB52E

P921

Q28646726-183CE259-F9DD-4B9B-8D47-87863D1D8ACF

P932

Q28646726-6C12B0E7-87E0-47CE-B669-0668BCB70C3A

P3181

P356

MCB.24.2.787-795.2004

P1433

Molecular and Cellular Biology

P1476

Dynamics of human immunodefici ...... ansactivation response element

@en

P2093

B. Matija Peterlin

http://www.w3.org/2001/XMLSchema#string

Dan Irwin

http://www.w3.org/2001/XMLSchema#string

Koh Fujinaga

http://www.w3.org/2001/XMLSchema#string

Ran Taube

http://www.w3.org/2001/XMLSchema#string

Takeshi Kurosu

http://www.w3.org/2001/XMLSchema#string

Yehong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro

Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex

DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs

Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA.

Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences

Domains in the SPT5 protein that modulate its transcriptional regulatory properties

Crystal structure of the RNA-binding domain of the U1 small nuclear ribonucleoprotein A

Activation of MyoD-dependent transcription by cdk9/cyclin T2

DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation

NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation

P304

787–795

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

894835

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/MCB.24.2.787-795.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5504952

http://www.w3.org/2001/XMLSchema#string

P698

14701750

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

343783

http://www.w3.org/2001/XMLSchema#string